- Joined
- May 30, 2011
- Messages
- 17,985
- Reaction score
- 34,554
Offline
The risk of developing acute coronary syndrome (ACS) significantly increased in patients after receiving mRNA COVID-19 vaccines, according to a report presented at the American Heart Association (AHA) Scientific Sessions 2021, held from November 13 to 15, 2021.
The study included 566 men and women (1:1) aged 28-97 years, who were patients in a preventive cardiology practice. All patients received a new PULS Cardiac Test 2-10 weeks after their second COVID-19 vaccine. This test result was compared with a PULS score from 3-5 months prevaccination. The PULS Cardiac Test measures multiple protein biomarkers, including hepatocyte growth factor [HGF], soluble Fas, and IL-16, and uses the results to calculate a 5-year risk score for new ACS. The PULS score increases with above-normal elevation. All participants received this test every 3-6 months for 8 years.
Beware that it’s not actually a published journal article. It’s a non-peer reviewed conference abstract. There is a single author, which is very unusual in medical academics. The author honestly, looks questionable. He certainly looks like a naturopath…which is fine, but it brings up concern over bias considering that he’s essentially on an island without a co-writer and without peer-review. Boy…the abstract is a mess. I read medical journal articles just about daily, and the abstract would have immediately raised red flags that there was poor editing and very likely not published in a legit journal.
The COVID vaccine is likely pro-inflammatory. I don’t think that many dispute that. After all it is provoking a powerful immune response and some level of side effects are common. But so what if this marker is transiently elevated after the vaccine? That does not necessarily mean that those patients had worse outcomes. So I don’t agree with CardiologyAdvisors interpretation. The website is written anonymously…it can be someone with literally no education summarizing the conference abstract. Also, there was no mention of actual COVID patients in their cohort. Did they also have elevated markers, and how did they compare to those just receiving the vaccine? And again…was there any impact on morbidity and mortality? That’s ultimately what matters. Pretty weak.
Last edited: